Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(CSE: GTTX )

0.1000 UNCHANGED
Official Closing Price Updated: 3:38 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,500
Open 0.1000
Bid (Size) 0.0250 (10,000)
Ask (Size) 0.1000 (1,500)
Prev. Close 0.1000
Today's Range 0.1000 - 0.1000
52wk Range 0.0150 - 0.1000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeneTether Therapeutics Announces Binding Term Sheet for Private Placement of Units and Exclusive License Agreement of Soft Tissue Sarcoma Drug Candidate
KELOWNA, BC & SAN JUAN, PR – October 11, 2024 – TheNewswire – GeneTether Therapeutics Inc. (CSE: GTTX) (“GeneTether” or the “Company”) today announced entry into a binding term sheet (the “Term Sheet”)... 
Via TheNewswire.com
The Power Play by The Market Herald Releases New Interviews with Datametrex, Cloud DX, Alkaline, and GeneTether Therapeutics
Via ACCESSWIRE

Performance

YTD
+100.00%
+100.00%
1 Month
+300.00%
+300.00%
3 Month
+566.67%
+566.67%
6 Month
+233.33%
+233.33%
1 Year
+400.00%
+400.00%

More News

Read More
The Power Play by The Market Herald Releases New Interview with GeneTether Therapeutics
From The Market Herald
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
The Power Play by The Market Herald Releases Interviews With Monarch Mining, Vox, Tocvan Ventures, GeneTether Therapeutics, Peloton Minerals, SWMBRD Sports, and BioVaxys Technology Corp.
From The Market Herald
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.